KUMULUS VAPE (ALVAP.PA) Fundamental Analysis & Valuation

EPA:ALVAP • FR0013419876

Current stock price

3.22 EUR
+0.02 (+0.63%)
Last:

This ALVAP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. ALVAP.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALVAP was profitable.
  • ALVAP had a negative operating cash flow in the past year.
  • ALVAP had positive earnings in each of the past 5 years.
  • In the past 5 years ALVAP reported 4 times negative operating cash flow.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • With an excellent Return On Assets value of 9.80%, ALVAP belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
  • ALVAP's Return On Equity of 16.02% is fine compared to the rest of the industry. ALVAP outperforms 77.78% of its industry peers.
  • ALVAP has a Return On Invested Capital of 12.74%. This is amongst the best in the industry. ALVAP outperforms 81.48% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALVAP is above the industry average of 9.51%.
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROIC 12.74%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.35%, ALVAP is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
  • ALVAP's Profit Margin has improved in the last couple of years.
  • ALVAP has a Operating Margin of 5.89%. This is in the better half of the industry: ALVAP outperforms 74.07% of its industry peers.
  • In the last couple of years the Operating Margin of ALVAP has grown nicely.
  • ALVAP has a worse Gross Margin (23.53%) than 72.22% of its industry peers.
  • In the last couple of years the Gross Margin of ALVAP has remained more or less at the same level.
Industry RankSector Rank
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ALVAP.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALVAP is creating value.
  • The number of shares outstanding for ALVAP remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for ALVAP has been increased compared to 5 years ago.
  • The debt/assets ratio for ALVAP has been reduced compared to a year ago.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 4.40 indicates that ALVAP is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of ALVAP (4.40) is better than 87.04% of its industry peers.
  • ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • ALVAP's Debt to Equity ratio of 0.21 is amongst the best of the industry. ALVAP outperforms 87.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.4
ROIC/WACC1.92
WACC6.63%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 3.30 indicates that ALVAP has no problem at all paying its short term obligations.
  • ALVAP's Current ratio of 3.30 is amongst the best of the industry. ALVAP outperforms 92.59% of its industry peers.
  • ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
  • ALVAP has a better Quick ratio (1.76) than 90.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALVAP.PA Growth Analysis

3.1 Past

  • The earnings per share for ALVAP have decreased strongly by -21.52% in the last year.
  • Measured over the past years, ALVAP shows a very strong growth in Earnings Per Share. The EPS has been growing by 97.48% on average per year.
  • ALVAP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.12%.
  • The Revenue has been growing by 41.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

  • ALVAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.70% yearly.
  • The Revenue is expected to decrease by -0.55% on average over the next years.
EPS Next Y-35.76%
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.55%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. ALVAP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 3.98, the valuation of ALVAP can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 98.15% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.51. ALVAP is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 5.90, the valuation of ALVAP can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 88.89% of the companies listed in the same industry.
  • ALVAP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 3.98
Fwd PE 5.9
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALVAP is valued cheaper than 94.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.99
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The decent profitability rating of ALVAP may justify a higher PE ratio.
  • ALVAP's earnings are expected to decrease with -2.70% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.04
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ALVAP.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.07%, ALVAP is a good candidate for dividend investing.
  • The stock price of ALVAP dropped by -23.15% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.36, ALVAP pays a better dividend. On top of this ALVAP pays more dividend than 92.59% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ALVAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.07%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

  • 17.40% of the earnings are spent on dividend by ALVAP. This is a low number and sustainable payout ratio.
DP17.4%
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALVAP.PA Fundamentals: All Metrics, Ratios and Statistics

KUMULUS VAPE

EPA:ALVAP (4/1/2026, 7:00:00 PM)

3.22

+0.02 (+0.63%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners37.47%
Ins Owner ChangeN/A
Market Cap9.76M
Revenue(TTM)60.68M
Net Income(TTM)2.64M
Analysts86.67
Price Target7.04 (118.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.07%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.4%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.85%
EPS NY rev (3m)-1.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 3.98
Fwd PE 5.9
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.73
EV/EBITDA 1.99
EPS(TTM)0.81
EY25.16%
EPS(NY)0.55
Fwd EY16.95%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS20.03
BVpS5.44
TBVpS4.42
PEG (NY)N/A
PEG (5Y)0.04
Graham Number9.96
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.02%
ROCE 17.82%
ROIC 12.74%
ROICexc 17.68%
ROICexgc 22.48%
OM 5.89%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexgc growth 3Y1.55%
ROICexgc growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.4
F-Score3
WACC6.63%
ROIC/WACC1.92
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.52%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y-35.76%
EPS Next 2Y-6.58%
EPS Next 3Y-2.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year-6.25%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.55%
Revenue Next 5YN/A
EBIT growth 1Y-24.22%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year-5.88%
EBIT Next 3Y2.86%
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A

KUMULUS VAPE / ALVAP.PA Fundamental Analysis FAQ

What is the fundamental rating for ALVAP stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALVAP.PA.


What is the valuation status of KUMULUS VAPE (ALVAP.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to KUMULUS VAPE (ALVAP.PA). This can be considered as Fairly Valued.


What is the profitability of ALVAP stock?

KUMULUS VAPE (ALVAP.PA) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for ALVAP stock?

The Earnings per Share (EPS) of KUMULUS VAPE (ALVAP.PA) is expected to decline by -35.76% in the next year.


How sustainable is the dividend of KUMULUS VAPE (ALVAP.PA) stock?

The dividend rating of KUMULUS VAPE (ALVAP.PA) is 7 / 10 and the dividend payout ratio is 17.4%.